ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,197Medicare Part D Prescriptions Filled, Including Refills

Rank: 131 out of 3734

$923K Total Retail Price of All Prescriptions

Rank: 133 out of 3734

650 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 650 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 650 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 11,583 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LISINOPRIL 698 563 1 3
LEVOTHYROXINE SODIUM 683 548 2 2
SIMVASTATIN 559 487 3 1
OMEPRAZOLE 439 282 4 4
FUROSEMIDE 436 324 5 7
METOPROLOL TARTRATE 388 323 6 6
METFORMIN HCL 376 243 7 8
AMLODIPINE BESYLATE 363 332 8 5
HYDROCODONE-ACETAMINOPHEN 343 201 S3 9 12
HYDROCHLOROTHIAZIDE 304 268 10 9
ESCITALOPRAM OXALATE 252 191 11 68
MIRTAZAPINE 248 195 12 45
ATENOLOL 241 219 13 13
POTASSIUM CHLORIDE 227 169 14 19
WARFARIN SODIUM 218 140 15 10
PRAVASTATIN SODIUM 199 122 16 15
RISPERIDONE 190 112 17 62
NAMENDA 189 183 18 44
RANITIDINE HCL 180 117 19 32
LOSARTAN POTASSIUM 178 149 20 21
CITALOPRAM HBR 177 105 21 16
BUSPIRONE HCL 177 120 21 129
GABAPENTIN 175 109 23 17
ATORVASTATIN CALCIUM 166 143 24 11
DONEPEZIL HCL 164 150 25 25
CLOPIDOGREL 164 134 25 23
QUETIAPINE FUMARATE 156 94 27 82
CARVEDILOL 139 102 28 30
PREDNISONE 133 92 29 42
METOPROLOL SUCCINATE 128 106 30 14
ALENDRONATE SODIUM 126 98 31 26
ISOSORBIDE MONONITRATE ER 120 120 32 34
PANTOPRAZOLE SODIUM 118 87 33 22
VENLAFAXINE HCL ER 112 44 34 84
TRAZODONE HCL 111 69 35 49
MELOXICAM 111 72 35 52
CLONIDINE HCL 105 84 37 79
TAMSULOSIN HCL 98 80 38 29
PLAVIX 98 80 38 39
FAMOTIDINE 96 72 40 60
LANTUS 95 86 41 54
FINASTERIDE 93 80 42 88
ALLOPURINOL 92 77 43 33
OXYCODONE HCL 90 52 S2 44 58
FENOFIBRATE 89 50 45 81
PAROXETINE HCL 89 61 45 59
SERTRALINE HCL 86 72 47 18
GLYBURIDE 85 50 R 48 64
DIVALPROEX SODIUM 81 31 49 99
ZOLPIDEM TARTRATE 81 56 49 24
AMITRIPTYLINE HCL 80 47 R 51 94
LISINOPRIL-HYDROCHLOROTHIAZIDE 77 76 52 27
ABILIFY 77 23 52 159
LAMOTRIGINE 75 0 54 169
SPIRONOLACTONE 75 66 54 80
SULFAMETHOXAZOLE-TRIMETHOPRIM 74 35 56 117
OXYCODONE-ACETAMINOPHEN 74 60 S2 56 51
NYSTATIN 73 59 58 162
POLYETHYLENE GLYCOL 3350 70 48 59 53
NEXIUM 70 52 59 36
LEVETIRACETAM 67 47 61 105
CELEBREX 65 61 62 69
PHENYTOIN SODIUM EXTENDED 63 26 63 149
LACTULOSE 63 41 63 137
CHLORHEXIDINE GLUCONATE 62 36 65 260
DIVALPROEX SODIUM ER 58 34 66 198
OLANZAPINE 58 35 66 106
SPIRIVA 58 45 66 40
ROPINIROLE HCL 57 41 69 118
SEROQUEL 57 46 69 161
TRAMADOL HCL 56 29 71 20
CEPHALEXIN 55 30 72 120
BENZTROPINE MESYLATE 55 34 R 72 173
TOPIRAMATE 55 13 72 181
DOXAZOSIN MESYLATE 54 28 75 100
DIGOXIN 54 41 75 43
LEXAPRO 54 41 75 236
INSULIN SYRINGE 52 39 78 109
SYNTHROID 51 51 79 47
TRIAMCINOLONE ACETONIDE 50 41 80 131
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 24, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.